Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism.

Pharmacogenomics - 1 May 2002

Cashman John R

Abstract excerpt

The human flavin-containing monooxygenases catalyze the oxygenation of nucleophilic heteroatom-containing drugs, xenobiotics and endogenous materials. Evidence for six forms of the FMO gene exist but it is FMO form 3 (FMO3) that is the prominent form in adult human liver that is likely to be associated with the bulk of FMO-mediated metabolism. An understanding of the substrate specificity of human FMO3 is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to FMO3 gene
Share to Gene Frequency
Share to Oxygenases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmaceutical Preparations

Share to Pharmacogenetics and Drug Metabolism

Share to Phenotype

Share to Polymorphism, Genetic

Share to Racial Groups

Source

Identifiers

PMID: 12052141
DOI: 10.1517/14622416.3.3.325

Genes

FMO3

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism.PMID 12052141Read ↗

Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation.Semantic proximity Read ↗

Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and diseaseSemantic proximity Read ↗

Flavin-containing monooxygenase 3 and human disease.Semantic proximity Read ↗

Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities.Semantic proximity Read ↗

Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development.Semantic proximity Read ↗

Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.Semantic proximity Read ↗

Human flavin-containing monooxygenases.Semantic proximity Read ↗

Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms.Semantic proximity Read ↗

Genetic Polymorphisms of Human Flavin-Containing Monooxygenase 3: Implications for Drug Metabolism and Clinical PerspectivesSemantic proximity Read ↗

Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication.Semantic proximity Read ↗

Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants.Semantic proximity Read ↗

Genetic polymorphisms of flavin-containing monooxygenase (FMO).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.